Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer

Increasing evidence supports the benefit of identifying BRCA1 and BRCA2 germline mutations in early breast cancer. Selection of patients for genetic testing is based on defined criteria taking individual and family history related factors into account. It is important to make a distinction between e...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Martin P., Winter, Christof, Kristoffersson, Ulf, Rehn, Martin, Larsson, Christer, Saal, Lao H., Loman, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357494/
https://www.ncbi.nlm.nih.gov/pubmed/28120249
http://dx.doi.org/10.1007/s10689-016-9953-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357494/
https://www.ncbi.nlm.nih.gov/pubmed/28120249
http://dx.doi.org/10.1007/s10689-016-9953-x

Ejemplares similares